DeutschNewstral
Article
Bbarrons.com on 2022-05-24 15:40
Who Will Lead Biogen? Here Are Some Likely Picks.3 min read
Related news
- BBiogen Announces New Trial for Alzheimer’s drug Aduhelm2 min readbarrons.com
- BBiogen to Eliminate Alzheimer's Drug Infrastructure, Search for New CEO1 min readbarrons.com
- MBiogen and Eisai make plans to take another Alzheimer's drug to the FDA3 min readmarketwatch.com
- BBiogen Lifts Profit Estimates. The Stock Rises.1 min readbarrons.com
- MBeset by challenges with its Alzheimer's disease drug, Biogen pivots3 min readmarketwatch.com
Biogen Sees Heavy Patient Interest in New Alzheimer’s Drug4 min readwsj.com- BBiogen Searches for New CEO in Wake of Struggles With Alzheimer's Drug 4 min readbarrons.com
- BBiogen Sold $1.6M of Aduhelm in Weeks After Approval. Earnings Were Strong.2 min readbarrons.com
- BBiogen Is Giving Away Its Controversial Alzheimer's Drug: Report 2 min readbarrons.com
- BNetflix, Tesla, Biogen, and More of Wednesday’s Stock Market Movers1 min readbarrons.com
- BBiogen in Pole Position After Roche's Alzheimer's Drug Disappoints3 min readbarrons.com
- BBiogen Says EU Regulator Takes 'Negative Opinion' on Its Alzheimer's Drug1 min readbarrons.com
- BWhy Biogen Could Need to Sell 'for Parts'3 min readbarrons.com
- BBiogen Is Still a Buy Despite Alzheimer's Drug Concerns, Analyst Says2 min readbarrons.com
- BBiogen Stock Can Go 'Decisively Higher' on Sales of Alzheimer's Drug2 min readbarrons.com
- MBiogen halts development of antibody drug aimed at Alzheimer's1 min readmarketwatch.com
- BBiogen Stock Is Falling Despite an Upbeat Outlook. Here's Why. 1 min readbarrons.com
- BRoche Sinks as Alzheimer's Drug Disappoints. Biogen is Gaining. 1 min readbarrons.com
- BBiogen Stock Is Tumbling Because Its Alzheimer's Drug Rollout Isn't Going So Well2 min readbarrons.com
- BBiogen After the Alzheimer’s Drug Debacle: Time to Sell the Parts? 4 min readbarrons.com